Iron intake and cardiovascular disease

Functional Foods, Cardiovascular Disease and Diabetes

Volumn , Issue , 2004, Pages 99-125

  Kartikasari, A E R ^a   Georgiou, N A ^a   Marx, J J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748689680     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-85573-735-8.50010-7     Document Type: Chapter

References (132)

1. ADAMS D.H., LLOYD A.R. 'Chemokines: leucocyte recruitment and activation cytokines'. Lancet 1997, 349(no. 9050):490-495.
2. ADAMS D.H., SHAW S. 'Leucocyte-endothelial interactions and regulation of leucocyte migration'. Lancet 1994, 343(no. 8901):831-836.
3. ARAUJO J.A., ROMANO E.L., BRITO B.E., PARTHE V., ROMANO M., BRACHO M., MONTANO R.F., CARDIER J. 'Iron overload augments the development of atherosclerotic lesions in rabbits'. Arterioscler. Thromb. Vasc. Biol. 1995, 15(no. 8):1172-1180.
4. ASCHERIO A., HUNTER D.J. 'Iron and myocardial infarction'. Epidemiology 1994, 5(no. 2):135-137.
5. ASCHERIO A., WILLETT W.C., RIMM E.B., GIOVANNUCCI E.L., STAMPFER M.J. 'Dietary iron intake and risk of coronary disease among men'. Circulation 1994, 89(no. 3):969-974.
6. ASCHERIO A., RIMM E.B., GIOVANNUCCI E., WILLETT W.C., STAMPFER M.J. 'Blood donations and risk of coronary heart disease in men'. Circulation 2001, 103(no. 1):52-57.
7. AUER J., RAMMER M., BERENT R., WEBER T., LASSNIG E., EBER B. 'Body iron stores and coronary atherosclerosis assessed by coronary angiography'. Nutr. Metab. Cardiovasc. Dis. 2002, 12(no. 5):285-290.
8. BADYLAK S.F., SIMMONS A., TUREK J., BABBS C.F. 'Protection from reperfusion injury in the isolated rat heart by postischaemic deferoxamine and oxypurinol administration'. Cardiovasc. Res. 1987, 21(no. 7):500-506.
9. BALDWIN A.S. 'Series introduction: the transcription factor NF-kappaB and human disease'. J. Clin. Invest. 2001, 107(no. 1):3-6.
10. BATTILORO E., OMBRES D., PASCALE E., D'AMBROSIO E., VERNA R., ARCA M. 'Haemochromatosis gene mutations and risk of coronary artery disease'. Eur. J Hum. Genet 2000, 8(no. 5):389-392.
11. BEATON G.H., COREY P.N., STEELE C. 'Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency'. Am. J. Clin. Nutr. 1989, 50(no. 3):575-585. Suppl.
12. BOLLI R., PATEL B.S., ZHU W.X., O'NEILL P.G., HARTLEY C.J., CHARLAT M.L., ROBERTS R. 'The iron chelator desferoxamine attenuates postischemic ventricular dysfunction'. Am. J. Physiol. 1987, 253(no. 6):H1372-H1380. Pt 2.
13. BREUER W., CABANTCHIK Z.I. 'A fluorescence-based one-step assay for serum non-transferrin-bound iron'. Anal. Biochem 2001, 299(no. 2):194-202.
14. BRITTENHAM G.M., FARRELL D.E., HARRIS J.W., FELDMAN E.S., DANISH E.H., MUIR W.A., TRIPP J.H., BELLON E.M. 'Magnetic-susceptibility measurement of human iron stores'. N. Engl. J. Med. 1982, 307(no. 27):1671-1675.
15. BRITTENHAM G.M., SHETH S., ALLEN C.J., FARRELL D.E. 'Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease'. Semin. Hematol. 2001, 38(no. 1):37-56. Suppl 1.
16. BURT M.J., HALLIDAY J.W., POWELL L.W. 'Iron and coronary heart disease'. BMJ 1993, 307(no. 6904):575-576.
17. BUTCHER E.C. 'Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity'. Cell 1991, 67(no. 6):1033-1036.
18. CAMASCHELLA C, ROETTO A., CALI A., DE GOBBI M., GAROZZO G., CARELLA M., MAJORANO N., TOTARO A., GASPARINI P. 'The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22'. Nat. Genet 2000, 25(no. 1):14-15.
19. CANDORE G., BALISTRERI C.R., LIO D., MANTOVANI V., COLONNA-ROMANO G., CHIAPPELLI M., TAMPIERI C., LICASTRO F., BRANZI A., AVERNA M. 'Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy'. Blood Cells, Molecules, Dis.s 2003, 31(no. 1):57-62.
20. CHEUNG Y.F., CHAN G.C., HA S.Y. 'Arterial stiffness and endothelial function in patients with beta-thalassemia major'. Circulation 2002, 106(no. 20):2561-2566.
21. COLLINS T., READ M.A., NEISH A.S., WHITLEY M.Z., THANOS D., MANIATIS T. 'Transcriptional regulation of endothelial cell adhesion molecules: Nf- kappa B and cytokine-inducible enhancers'. FASEB J. 1995, 9(no. 10):899-909.
22. CONRAD M.E., UMBREIT J.N., MOORE E.G. 'Iron absorption and transport'. Am J Med. Sci. 1999, 318(no. 4):213-229.
23. COOK J.D., FINCH C.A., SMITH N.J. 'Evaluation of the iron status of a population'. Blood 1976, 48(no. 3):449-455.
24. DEDHAR S. 'Integrins and signal transduction'. Curr. Opin. Hematol. 1999, 6(no. 1):37-43.
25. DE VALK B., MARX J.J. 'Iron, atherosclerosis, and ischemic heart disease'. Arch. Intern. Med. 1999, 159(no. 14):1542-1548.
26. DE VALK B., ADDICKS M.A., GOSRIWATANA I., LU S., HIDER R.C., MARX J.J. 'Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes'. Eur. J. Clin. Invest. 2000, 30(no. 3):248-251.
27. DIAZ M.N., FREI B., VITA J.A., KEANEY J.F. 'Antioxidants and atherosclerotic heart disease'. N. Engl. J. Med. 1997, 337(no. 6):408-416.
28. DRAKESMITH H., SWEETLAND E., SCHIMANSKI L., EDWARDS J., COWLEY D., ASHRAF M., BASTIN J., TOWNSEND A.R. 'The hemochromatosis protein HFE inhibits iron export from macrophages'. Proc. Natl. Acad. Sci. U.S.A 2002, 99(no. 24):15602-15607.
29. DUFFY S.J., BIEGELSEN E.S., HOLBROOK M., RUSSELL J.D., GOKCE N., KEANEY J.F., VITA J.A. 'Iron chelation improves endothelial function in patients with coronary artery disease'. Circulation 2001, 103(no. 23):2799-2804.
30. DZAU V.J., BRAUN-DULLAEUS R.C., SEDDING D.G. 'Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies'. Nat. Med. 2002, 8(no. 11):1249-1256.
31. EBNET K., VESTWEBER D. 'Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines'. Histochem. Cell Biol. 1999, 112(no. 1):1-23.
32. EBNET K., KALDJIAN E.P., ANDERSON A.O., SHAW S. 'Orchestrated information transfer underlying leukocyte endothelial interactions'. Annu. Rev. Immunol. 1996, 14:155-177.
33. EICHNER J.E., QI H., MOORE W.E., SCHECHTER E. 'Iron measures in coronary angiography patients'. Atherosclerosis 1998, 136(no. 2):241-245.
34. ESPOSITO B.P., BREUER W., SIRANKAPRACHA P., POOTRAKUL P., HERSHKO C., CABANTCHIK Z.I. 'Labile plasma iron in iron overload: redox activity and susceptibility to chelation'. Blood 2003, 102(no. 7):2670-2677.
35. FAILLA M., GIANNATTASIO C., PIPERNO A., VERGANI A., GRAPPIOLO A, GENTILE G., MELES E., MANCIA G. 'Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy'. Hepatology 2000, 32(no. 3):569-573.
36. FEDER J.N., GNIRKE A., THOMAS W., TSUCHIHASHI Z., RUDDY D.A., BASAVA A., DORMISHIAN F., DOMINGO R., ELLIS M.C., FULLAN A., HINTON L.M., JONES N.L., KIMMEL B.E., KRONMAL G.S., LAUER P., LEE V.K., LOEB D.B., MAPA F.A., MCCLELLAND E., MEYER N.C., MINTIER G.A., MOELLER N., MOORE T., MORDCANG E., WOLFF R.K. 'A novel Mhc class I-like gene is mutated in patients with hereditary haemochromatosis'. Nat. Genet 1996, 13(no. 4):399-408.
37. FOX C.J., CULLEN D.J., KNUIMAN M.W., CUMPSTON G.N., DIVITINI M.L., ROSSI E., GOCHEE P.A., POWELL L.W., OLYNYK J.K. 'Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study'. J. Cardiovasc. Risk 2002, 9(no. 5):287-293.
38. FRANCO R.F., ZAGO M.A., TRIP M.D., TEN CATE H., VAN DEN E.A., PRINS M.H., KASTELEIN J.J., REITSMA P.H. 'Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease'. Br. J Haematol. 1998, 102(no. 5):1172-1175.
39. FREY G.H., KRIDER D.W. 'Serum ferritin and myocardial infarct'. W. V. Med. J. 1994, 90(no. 1):13-15.
40. GAHMBERG C.G. 'Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules'. Curr. Opin. Cell Biol. 1997, 9(no. 5):643-650.
41. GATTER K.C., BROWN G., TROWBRIDGE I.S., WOOLSTON R.E., MASON D.Y. 'Transferrin receptors in human tissues: their distribution and possible clinical relevance'. J. Clin. Pathol. 1983, 36(no. 5):539-545.
42. GERRITY R.G. 'The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions'. Am. J. Pathol. 1981, 103(no. 2):181-190.
43. GIARDINA P.J., GRADY R.W. 'Chelation therapy in beta-thalassemia: an optimistic update'. Semin. Hematol. 2001, 38(no. 4):360-366.
44. GORDON T., KANNEL W.B., HJORTLAND M.C., MCNAMARA P.M. 'Menopause and coronary heart disease. The Framingham Study'. Ann. Intern. Med. 1978, 89(no. 2):157-161.
45. GRASBECK R., KOUVONEN I., LUNDBERG M., TENHUNEN R. 'An intestinal receptor for heme'. Scand. J Haematol. 1979, 23(no. 1):5-9.
46. GROOTVELD M., BELL J.D., HALLIWELL B., ARUOMA O.I., BOMFORD A., SADLER P.J. 'Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy'. J. Biol Chem 1989, 264(no. 8):4417-4422.
47. GUNSHIN H., MACKENZIE B., BERGER U.V., GUNSHIN Y., ROMERO M.F., BORON W.F., NUSSBERGER S., GOLLAN J.L., HEDIGER M.A. 'Cloning and characterization of a mammalian proton-coupled metal-ion transporter'. Nature 1997, 388(no. 6641):482-488.
48. GUNSHIN H., ALLERSON C.R., POLYCARPOU-SCHWARZ M., ROFTS A., ROGERS J.T., KISHI F., HENTZE M.W., ROUAULT T.A., ANDREWS N.C., HEDIGER M.A. 'Iron-dependent regulation of the divalent metal ion transporter'. FEBS Lett 2001, 509(no. 2):309-316.
49. HAIDARI M., JAVADI E., SANATI A, HAJILOOI M., GHANBILI J. 'Association of increased ferritin with premature coronary stenosis in men'. Clin. Chem 2001, 47(no. 9):1666-1672.
50. HARRISON P.M., AROSIO P. 'The ferritins: molecular properties, iron storage function and cellular regulation'. Biochim. Biophys. Acta 1996, 1275(no. 3):161-203.
51. HEINECKE J.W., ROSEN H., CHAIT A. 'Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture'. J. Clin. Invest. 1984, 74(no. 5):1890-1894.
52. HENTZE M.W., CAUGHMAN S.W., ROUAULT T.A., BARRIOCANAL J.G., DANCIS A., HARFORD J.B., KLAUSNER R.D. 'Identification of the iron-responsive element for the translational regulation of human ferritin mRNA'. Science 1987, 238(no. 4833):1570-1573.
53. HETET G., ELBAZ A, GARIEPY J., NICAUD V., ARVEILER D., MORRISON C., KEE F., EVANS A., SIMON A., AMARENCO P., CAMBIEN F., GRANDCHAMP B. 'Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases'. Eur. J. Clin. Invest. 2001, 31(no. 5):382-388.
54. HJORTLAND M.C., MCNAMARA P.M., KANNEL W.B. 'Some atherogenic concomitants of menopause: The Framingham Study'. Am. J. Epidemiol. 1976, 103(no. 3):304-311.
55. HUEHNS E.R., PORTER J.B., HIDER R.C. 'Selection of hydroxypyridin-4-ones for the treatment of iron overload using in vitro and in vivo models'. Hemoglobin 1988, 12(no. 5-6):593-600.
56. KANNEL W.B., HJORTLAND M.C., MCNAMARA P.M., GORDON T. 'Menopause and risk of cardiovascular disease: the Framingham study'. Ann. Intern. Med. 1976, 85(no. 4):447-452.
57. KATO J., FUJIKAWA K., KANDA M., FUKUDA N., SASAKI K., TAKAYAMA T., KOBUNE M., TAKADA K., TAKIMOTO R., HAMADA H., IKEDA T., NIITSU Y. 'A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload'. Am. J. Hum. Genet 2001, 69(no. 1):191-197.
58. KIECHL S., AICHNER F., GERSTENBRAND F., EGGER G., MAIR A., RUNGGER G., SPOGLER F., JAROSCH E., OBERHOLLENZER F., WILLEIT J. 'Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study'. Arterioscler. Thromb 1994, 14(no. 10):1625-1630.
59. KIECHL S., WILLEIT J., EGGER G., POEWE W., OBERHOLLENZER F. 'Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study'. Circulation 1997, 96(no. 10):3300-3307.
60. KLIPSTEIN-GROBUSCH K., KOSTER J.F., GROBBEE D.E., DENBREEIJEN J.H., BOEING H., HOFMAN A., WITTEMAN J.C. 'Dietary iron and risk of myocardial infarction in the Rotterdam Study'. Am. J. Epidemiol. 1999, 149(no. 5):421-428.
61. KLIPSTEIN-GROBUSCH K., KOSTER J.F., GROBBEE D.E., LINDEMANS J., BOEING H., HOFMAN A., WITTEMAN J.C. 'Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study'. Am. J. Clin. Nutr. 1999, 69(no. 6):1231-1236.
62. KOLODGIE F.D., GOLD H.K., BURKE A.P., FOWLER D.R., KRUTH H.S., WEBER D.K., FARB A., GUERRERO L.J., HAYASE M., KUTYS R., NARULA J., FINN A.V., VIRMANI R. 'Intraplaque hemorrhage and progression of coronary atheroma'. N. Engl. J Med. 2003, 349(no. 24):2316-2325.
63. KONTOGHIORGHES G.J., AGARWAL M.B., GRADY R.W., KOLNAGOU A., MARX J.J. 'Deferiprone for thalassaemia'. Lancet 2000, 356(no. 9227):428-429.
64. KOO S.W., CASPER K.A., OTTO K.B., GIRA A.K., SWERLICK R.A. 'Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells'. J. Invest. Dermatol. 2003, 120(no. 5):871-879.
65. LAUFFER R.B. 'Iron stores and the international variation in mortality from coronary artery disease'. Med. Hypotheses 1991, 35(no. 2):96-102.
66. LEE F.Y., LEE T.S., PAN C.C., HUANG A.L., CHAU L.Y. 'Colocalization of iron and ceroid in human atherosclerotic lesions'. Atherosclerosis 1998, 138(no. 2):281-288.
67. LEE H.T., CHIU L.L., LEE T.S., TSAI H.L., CHAU L.Y. 'Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice'. J. Biomed. Sci. 2003, 10(no. 5):510-517.
68. LEE T.S., LEE F.Y., PANG J.H., CHAU L.Y. 'Erythrophagocytosis and iron deposition in atherosclerotic lesions'. Chin. J. Physiol. 1999, 42(no. 1):17-23.
69. LEE T.S., SHIAO M.S., PAN C.C., CHAU L.Y. 'Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice'. Circulation 1999, 99(no. 9):1222-1229.
70. LIAO Y., COOPER R.S., MCGEE D.L. 'Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study'. Am. J. Epidemiol. 1994, 139(no. 7):704-712.
71. LIVREA M.A., TESORIERE L., MAGGIO A, D'ARPA D., PINTAUDI A.M., PEDONE E. 'Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia'. Blood 1998, 92(no. 10):3936-3942.
72. LOPEZ M., RIOS E., SCHLESINGER L., OLIVARES M., NUNEZ M.T., MUNOZ C. 'Tumour necrosis factor-alpha transcription in transferrin-stimulated human blood mononuclear cells: is transferrin receptor involved in the signalling mechanism?'. Br. J. Haematol. 2003, 120(no. 5):829-835.
73. LOREAL O., GOSRIWATANA I., GUYADER D., PORTER J., BRISSOT P., HIDER R.C. 'Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method'. J. Hepatol. 2000, 32(no. 5):727-733.
74. LUSCINSKAS F.W., KANSAS G.S., DING H., PIZCUETA P., SCHLEIFFENBAUM B.E., TEDDER T.F., GMBRONE M.A. 'Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins'. J. Cell Biol. 1994, 125(no. 6):1417-1427.
75. MANTTARI M, MANNINEN V., HUTTUNEN J.K., PALOSUO T., EHNHOLM C., HEINONEN O.P., FRICK M.H. 'Serum ferritin and ceruloplasmin as coronary risk factors'. Eur. Heart J. 1994, 15(no. 12):1599-1603.
76. MARX J.J., VAN ASBECK B.S. 'Use of iron chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage'. Acta Haematol. 1996, 95(no. 1):49-62.
77. MCKIE A.T., MARCIANI P., ROLFS A., BRENNAN K., WEHR K., BARROW D., MIRET S., BOMFORD A., PETERS T.J., FARZANEH F., HEDIGER M.A., HENTZE M.W., SIMPSON R.J. 'A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation'. Mol. Cell 2000, 5(no. 2):299-309.
78. MCKIE A.T., BARROW D., LATUNDE-DADA G.O., ROLFS A., SAGER G., MUDALY E., MUDALY M., RICHARDSON C., BARLOW D., BOMFORD A., PETERS T.J., RAJA K.B., SHIRALI S., HEDIGER M.A., FARZANEH F., SIMPSON R.J. 'An iron-regulated ferric reductase associated with the absorption of dietary iron'. Science 2001, 291(no. 5509):1755-1759.
79. MEERSCHAERT J., FURIE M.B. 'The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium'. J. Immunol. 1995, 154(no. 8):4099-4112.
80. MEYERS D.G., JENSEN K.C., MENITOVE J.E. 'A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events'. Transfusion 2002, 42(no. 9):1135-1139.
81. MINQIN R., WATT F., HUAT B.T., HALLIWELL B. 'Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions'. Free Radic. Biol. Med. 2003, 34(no. 6):746-752.
82. MONTOSI G., DONOVAN A., TOTARO A., GARUTI C., PIGNATTI E., CASSANELLI S., TRENOR C.C., GASPARINI P., ANDREWS N.C., PIETRANGELO A. 'Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene'. J. Clin. Invest. 2001, 108(no. 4):619-623.
83. MOORE M., FOLSOM A.R., BARNES R.W., ECKFELDT J.H. 'No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study'. Am. J. Epidemiol. 1995, 141(no. 8):719-723.
84. MORRISON H.I., SEMENCIW R.M., MAO Y., WIGLE D.T. 'Serum iron and risk of fatal acute myocardial infarction'. Epidemiology 1994, 5(no. 2):243-246.
85. MOURA E., NOORDERMEER M.A., VERHOEVEN N., VERHEUL A.F., MARX J.J. 'Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients'. Blood 1998, 92(no. 7):2511-2519.
86. NASSAR B.A., ZAYED E.M., TITLE L.M., O'NEILL B.J., BATA I.R., KIRKLAND S.A., DUNN J., DEMPSEY G.I., TAN M.H., JOHNSTONE D.E. 'Relation of HFE gene mutations, high iron stores and early onset coronary artery disease'. Can. J Cardiol. 1998, 14(no. 2):215-220.
87. NAVAB M., HAMA S.Y., NGUYEN T.B., FOGELMAN A.M. 'Monocyte adhesion and transmigration in atherosclerosis'. Coron. Artery Dis. 1994, 5(no. 3):198-204.
88. NEISH A.S., WILLIAMS A.J., PALMER H.J., WHITLEY M.Z., COLLINS T. 'Functional analysis of the human vascular cell adhesion molecule 1 promoter'. J. Exp. Med. 1992, 176(no. 6):1583-1593.
89. NICOLAS G., BENNOUN M., DEVAUX I., BEAUMONT C., GRANDCHAMP B., KAHN A., VAULONT S. 'Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice'. Proc. Natl. Acad. Sci. U. S. A 2001, 98(no. 15):8780-8785.
90. NJAJOU O.T., VAESSEN N., JOOSSE M., BERGHUIS B., VAN DONGEN J.W., BREUNING M.H., SNIJDERS P.J., RUTTEN W.P., SANDKUIJL L.A., OOSTRA B.A., VAN DUIJN C.M., HEUTINK P. 'A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis'. Nat. Genet 2001, 28(no. 3):213-214.
91. O'BRIEN K.D., ALLEN M.D., MCDONALD T.O., CHAIT A, HARLAN J.M., FISHBEIN D., MCCARTY J., FERGUSON M., HUDKINS K., BENJAMIN C.D. 'Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis'. J. Clin. Invest. 1993, 92(no. 2):945-951.
92. O'BRIEN K.D., MCDONALD T.O., CHAIT A., ALLEN M.D., ALPERS C.E. 'Neovascular expression of E-selectin, intercellular adhesion molecule- 1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content'. Circulation 1996, 93(no. 4):672-682.
93. OEXLE H., KASER A., MOST J., BELLMANN-WEILER R., WERNER E.R., WERNER-FELMAYER G., WEISS G. 'Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells'. J. Leukoc. Biol. 2003, 74(no. 2):287-294.
94. PANG J.H., JIANG M.J., CHEN Y.L., WANG F.W., WANG D.L., CHU S.H., CHAU L.Y. 'Increased ferritin gene expression in atherosclerotic lesions'. J. Clin. Invest. 1996, 97(no. 10):2204-2212.
95. PERKINS K.W., MCINNES I.W., BLACKBURN C.R., BEAL R.W. 'Idiopathic haemochromatosis in children; report of a family'. Am. J. Med. 1965, 39:118-126.
96. POWELL L.W., JAZWINSKA E., HALLIDAY J. 'Changing concepts of haemochromatosis'. Adv. Exp. Med. Biol. 1994, 356:285-291.
97. POWELL L.W., SUBRAMANIAM V.N., YAPP T.R. 'Haemochromatosis in the new millennium'. J. Hepatol. 2000, 32(no. 1):48-62. Suppl.
98. PRINTSEVA O.Y., PECLO M.M., GOWN A.M. 'Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3'. Am. J. Pathol. 1992, 140(no. 4):889-896.
99. RASMUSSEN M.L., FOLSOM A.R., CATELLIER D.J., TSAI M.Y., GARG U., ECKFELDT J.H. 'A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study'. Atherosclerosis 2001, 154(no. 3):739-746.
100. RAURAMAA R., VAISANEN S., MERCURI M., RANKINEN T., PENTTILA I., BOND M.G. 'Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men'. Eur. Heart J. 1994, 15(no. 8):1020-1027.
101. REDDY B.R., KLONER R.A., PRZYKLENK K. 'Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury'. Free Radic. Biol. Med. 1989, 7(no. 1):45-52.
102. ROEST M., VAN DER SCHOUW Y.T., DE VALK B., MARX J.J., TEMPELMAN M.J., DE GROOT P.G., SIXMA J.J., BANGA J.D. 'Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women'. Circulation 1999, 100(no. 12):1268-1273.
103. ROOYAKKERS T.M., STROES E.S., KOOISTRA M.P., VAN FAASSEN E.E., HIDER R.C., RABELINK T.J., MARX J.J. 'Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo'. Eur. J. Clin. Invest. 2002, 32(Suppl 1):9-16.
104. ROSS R. 'Cell biology of atherosclerosis'. Annu. Rev. Physiol. 1995, 57:791-804.
105. ROSS R. 'Atherosclerosis is an inflammatory disease'. Am. Heart J. 1999, 138(no. 5):S419-S420. Pt 2.
106. SALONEN J.T., NYYSSONEN K., KORPELA H., TUOMILEHTO J., SEPPANEN R., SALONEN R. 'High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men'. Circulation 1992, 86(no. 3):803-811.
107. SALONEN J.T., TUOMAINEN T.P., SALONEN R, LAKKA T.A., NYYSSONEN K. 'Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study'. American Journal of Epidemiology 1998, 148(no. 5):445-451.
108. SHANG X.Z., ISSEKUTZ A.C. 'Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers'. Eur. J. Immunol. 1998, 28(no. 6):1970-1979.
109. SLACK J. 'Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states'. Lancet 1969, 2(no. 7635):1380-1382.
110. SMITH C., MITCHINSON M.J., ARUOMA O.I., HALLIWELL B. 'Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions'. Biochem. J. 1992, 286(Pt 3):901-905.
111. SNOWDON D.A., PHILLIPS R.L., FRASER G.E. 'Meat consumption and fatal ischemic heart disease'. Prev. Med. 1984, 13(no. 5):490-500.
112. SOLYMOSS B.C., MARCIL M., GILFIX B.M., GELINAS F., POITRAS A.M., CAMPEAU L. 'The place of ferritin among risk factors associated with coronary artery disease'. Coron. Artery Dis. 1994, 5(no. 3):231-235.
113. SPRINGER T.A. 'Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm'. Cell 1994, 76(no. 2):301-314.
114. SPRINGER T.A. 'Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration'. Annu. Rev. Physiol. 1995, 57:827-872.
115. STONE N.J., LEVY R.I., FREDRICKSON D.S., VERTER J. 'Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia'. Circulation 1974, 49(no. 3):476-488.
116. SULLIVAN J.L. 'Iron and the sex difference in heart disease risk'. Lancet 1981, 1(no. 8233):1293-1294.
117. SULLIVAN J.L. 'The iron paradigm of ischemic heart disease'. Am. Heart J. 1989, 117(no. 5):1177-1188.
118. SULLIVAN J.L. 'Blood donation may be good for the donor. Iron, heart disease, and donor recruitment'. Vox Sang 1991, 61(no. 3):161-164.
119. SZKARADKIEWICZ A. 'Interleukin 1 production by human monocytes induced in culture with K562 cells'. Res. Exp. Med. (Berl) 1991, 191(no. 3):201-208.
120. TUOMAINEN T.P., NYYSSONEN K., SALONEN R., TERVAHAUTA A., KORPELA H., LAKKA T., KAPLAN G.A., SALONEN J.T. 'Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men'. Diabetes Care 1997, 20(no. 3):426-428.
121. TUOMAINEN T.P., SALONEN R., NYYSSONEN K., SALONEN J.T. 'Cohort Study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland'. BMJ 1997, 314(no. 7083):793-794.
122. TUOMAINEN T.P., PUNNONEN K., NYYSSONEN K., SALONEN J.T. 'Association between body iron stores and the risk of acute myocardial infarction in men'. Circulation 1998, 97(no. 15):1461-1466.
123. TUOMAINEN T.P., KONTULA K., NYYSSONEN K., LAKKA T.A., HELIO T., SALONEN J.T. 'Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland'. Circulation 1999, 100(no. 12):1274-1279.
124. TZONOU A., LAGIOU P., TRICHOPOULOU A., TSOUTSOS V., TRICHOPOULOS D. 'Dietary iron and coronary heart disease risk: a study from Greece'. Am J Epidemiol. 1998, 147(no. 2):161-166.
125. VAN DER KRAAIJ A.M., MOSTERT L.J., VAN EIJK H.G., ROSTER J.F. 'Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine'. Circulation 1988, 78(no. 2):442-449.
126. VAN DER KRAAIJ A.M., VAN EIJK H.G., KOSTER J.F. 'Prevention of postischemic cardiac injury by the orally active ion chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3'. Circulation 1989, 80(no. 1):158-164.
127. VAN DER WAL A.C., DAS P.K., TIGGES A.J., BECKER A.E. 'Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions'. Am. J. Pathol. 1992, 141(no. 6):1427-1433.
128. VISSEREN F.L., VERKERK M.S., VAN DER B.T., MARX J.J., VAN ASBECK B.S., DIEPERSLOOT R.J. 'Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A'. Eur. J. Clin. Invest. 2002, 32(Suppl 1):84-90.
129. VOOGD A., SLUITER W., VAN EIJK H.G., KOSTER J.F. 'Low molecular weight iron and the oxygen paradox in isolated rat hearts'. J. Clin. Invest. 1992, 90(no. 5):2050-2055.
130. WILLIAMS R.E., ZWEIER J.L., FLAHERTY J.T. 'Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts'. Circulation 1991, 83(no. 3):1006-1014.
131. WOLFF B., VOLZKE H., LUDEMANN J., ROBINSON D., VOGELGESANG D., STAUDT A., KESSLER C., DAHM J.B., JOHN U., FELIX S.B. 'Association between high serum ferritin Levels and carotid atherosclerosis in the Study of Health in Pomerania (SHIP)'. Stroke 2004, 35(no. 2):453-457.
132. ZHANG W.J., FREI B. 'Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells'. Free Radic. Biol. Med. 2003, 34(no. 6):674-682.